KB
Klothea Bio, Inc.
SEC filingOther Health Care · Miami, FL
Amount raised$6.9Msold at filing
Total offering$10.4M$3.5M still open
Investors in the raise22count reported to the SEC
FiledSep 8, 2026first sale Oct 11, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Olivier B. JarryExecutive Officer
Walter B. SchmidtDirector
Petr B. SramekDirector
Agustin B. Fernandez Santana IIIExecutive Officer, Director
Jeffrey B. MaddenExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.